Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA. Gastroparesis is a disease of the muscles of the stomach or the nerves controlling the muscles that causes the muscles to stop working, which can result in inadequate grinding of food by the stomach and poor emptying of food from the stomach into the intestine.
Gastroparesis remains a challenging syndrome to manage, with few effective treatments and a lack of rigorously controlled trials. One possible approach to treatment is based on the hypothesis that some of the symptoms (e.g., nausea, pain) arise because of changes in certain nerves. Tricyclic antidepressants are a category of drug often used to treat refractory (not yielding readily to treatment) symptoms of nausea, vomiting, and abdominal pain, according to background information in the article.
Henry P. Parkman, M.D., of Temple University, Philadelphia, and colleagues randomized 130 patients with idiopathic gastroparesis to nortriptyline (n = 65) or placebo (n = 65) to determine whether treatment with the tricyclic antidepressant nortriptyline would result in improvement of symptoms. Study drug dose was increased at 3-week intervals. The primary outcome measure was a decrease in the patient's Gastroparesis Cardinal Symptom Index (GCSI) score of at least 50 percent on 2 consecutive visits during 15 weeks of treatment.
The researchers found that the proportion of patients experiencing symptomatic improvement on 2 visits did not differ between the treatment groups: 15 (23 percent) in the nortriptyline group vs. 14 (21 percent) in the placebo group. There were also no treatment group differences in measures of nausea, fullness or early satiety, or bloating. Treatment was stopped more often in the nortriptyline group (29 percent) than in the placebo group (9 percent), but numbers of adverse events were not different.
"Our results raise general doubts about the utility of tricyclic antidepressants in low doses as a strategy for the treatment of idiopathic gastroparesis," the authors conclude.
Explore further: Johns Hopkins GI doctors use endoscopy to place transpyloric stent
More information: doi:10.l001/jama.2013.282833
Medical Xpress on facebook
Related Stories
Johns Hopkins GI doctors use endoscopy to place transpyloric stent
Jul 03, 2013
Physicians at Johns Hopkins say they are encouraged by early results in three patients of their new treatment for gastroparesis, a condition marked by the failure of the stomach to properly empty its contents into the small ...
Dietary intervention reduces stomach problems for diabetes patients
Oct 04, 2013
Many diabetes patients suffer from symptoms such as nausea, vomiting and lack of appetite. A doctoral thesis from the Sahlgrenska Academy shows that a diet consisting of foods that fall apart easily, for example boiled potatoes ...
Chronic electrical stimulation at acupressure points may relieve stomach woes for diabetics
Oct 22, 2012
Diabetic patients who suffer from a common complication of diabetes called gastroparesis may find that chronic electrical stimulation (ES) at specific acupuncture points could relieve gastroparesis symptoms such as nausea, ...
Are older antidepressants better for depression in Parkinson's disease?
Dec 17, 2008
A new study shows that antidepressant drugs which only affect serotonin, often used as first choice treatments, may not be best for depression in people with Parkinson's disease. The new research is published in the December ...
Drug improves remission of Crohn disease among children and adolescents
Nov 26, 2013
Among children and adolescents with Crohn disease not responding to treatment, use of the drug thalidomide resulted in improved clinical remission after 8 weeks of treatment compared with placebo, according to a study appearing ...
Recommended for you
Adding cognitive behavioral therapy to treatment of pediatric migraine improves relief of symptoms
1 seconds ago
Among children and adolescents with chronic migraine, the use of cognitive behavioral therapy (CBT) resulted in greater reductions in headache frequency and migraine-related disability compared with headache education, according ...
Widely-used anti-inflammatory drug shows success in treatment of amyloidosis
4 seconds ago
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced ...
Genetic clue to fighting new strains of flu
9 hours ago
(Medical Xpress)—Researchers at the University of Melbourne have discovered a genetic marker that can accurately predict which patients will experience more severe disease in a new strain of influenza (H7N9) ...
59 test positive for TB after Las Vegas outbreak
22 hours ago
Las Vegas public health officials say dozens of people linked to a tuberculosis outbreak at a neonatal unit have tested positive for the disease.
Johns Hopkins review throws doubt on wound care treatment
23 hours ago
A systematic review of 66 research papers focused on the treatment of skin ulcers suggests that most are so technically flawed that their results are unreliable. And even of those that pass muster, there is only weak evidence ...
Antibiotics before heart surgery protect against infection
Dec 23, 2013
A new study found preoperative antibiotic therapy administered within two hours of cardiac surgery decreased the risk of developing surgical site infections (SSIs) significantly. The study was published in the January issue ...
User comments
© Medical Xpress 2011-2013, Science X network
Among patients with idiopathic (of unknown cause) gastroparesis, use of the antidepressant nortriptyline compared with placebo for 15 weeks did not result in improvement in overall symptoms, according to a study appearing in the December 25 issue of JAMA. Gastroparesis is a disease of the muscles of the stomach or the nerves controlling the muscles that causes the muscles to stop working, which can result in inadequate grinding of food by the stomach and poor emptying of food from the stomach into the intestine.
Gastroparesis remains a challenging syndrome to manage, with few effective treatments and a lack of rigorously controlled trials. One possible approach to treatment is based on the hypothesis that some of the symptoms (e.g., nausea, pain) arise because of changes in certain nerves. Tricyclic antidepressants are a category of drug often used to treat refractory (not yielding readily to treatment) symptoms of nausea, vomiting, and abdominal pain, according to background information in the article.
Henry P. Parkman, M.D., of Temple University, Philadelphia, and colleagues randomized 130 patients with idiopathic gastroparesis to nortriptyline (n = 65) or placebo (n = 65) to determine whether treatment with the tricyclic antidepressant nortriptyline would result in improvement of symptoms. Study drug dose was increased at 3-week intervals. The primary outcome measure was a decrease in the patient's Gastroparesis Cardinal Symptom Index (GCSI) score of at least 50 percent on 2 consecutive visits during 15 weeks of treatment.
The researchers found that the proportion of patients experiencing symptomatic improvement on 2 visits did not differ between the treatment groups: 15 (23 percent) in the nortriptyline group vs. 14 (21 percent) in the placebo group. There were also no treatment group differences in measures of nausea, fullness or early satiety, or bloating. Treatment was stopped more often in the nortriptyline group (29 percent) than in the placebo group (9 percent), but numbers of adverse events were not different.
"Our results raise general doubts about the utility of tricyclic antidepressants in low doses as a strategy for the treatment of idiopathic gastroparesis," the authors conclude.
Explore further: Johns Hopkins GI doctors use endoscopy to place transpyloric stent
More information: doi:10.l001/jama.2013.282833
Medical Xpress on facebook
Related Stories
Johns Hopkins GI doctors use endoscopy to place transpyloric stent
Jul 03, 2013
Physicians at Johns Hopkins say they are encouraged by early results in three patients of their new treatment for gastroparesis, a condition marked by the failure of the stomach to properly empty its contents into the small ...
Dietary intervention reduces stomach problems for diabetes patients
Oct 04, 2013
Many diabetes patients suffer from symptoms such as nausea, vomiting and lack of appetite. A doctoral thesis from the Sahlgrenska Academy shows that a diet consisting of foods that fall apart easily, for example boiled potatoes ...
Chronic electrical stimulation at acupressure points may relieve stomach woes for diabetics
Oct 22, 2012
Diabetic patients who suffer from a common complication of diabetes called gastroparesis may find that chronic electrical stimulation (ES) at specific acupuncture points could relieve gastroparesis symptoms such as nausea, ...
Are older antidepressants better for depression in Parkinson's disease?
Dec 17, 2008
A new study shows that antidepressant drugs which only affect serotonin, often used as first choice treatments, may not be best for depression in people with Parkinson's disease. The new research is published in the December ...
Drug improves remission of Crohn disease among children and adolescents
Nov 26, 2013
Among children and adolescents with Crohn disease not responding to treatment, use of the drug thalidomide resulted in improved clinical remission after 8 weeks of treatment compared with placebo, according to a study appearing ...
Recommended for you
Adding cognitive behavioral therapy to treatment of pediatric migraine improves relief of symptoms
1 seconds ago
Among children and adolescents with chronic migraine, the use of cognitive behavioral therapy (CBT) resulted in greater reductions in headache frequency and migraine-related disability compared with headache education, according ...
Widely-used anti-inflammatory drug shows success in treatment of amyloidosis
4 seconds ago
A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced ...
Genetic clue to fighting new strains of flu
9 hours ago
(Medical Xpress)—Researchers at the University of Melbourne have discovered a genetic marker that can accurately predict which patients will experience more severe disease in a new strain of influenza (H7N9) ...
59 test positive for TB after Las Vegas outbreak
22 hours ago
Las Vegas public health officials say dozens of people linked to a tuberculosis outbreak at a neonatal unit have tested positive for the disease.
Johns Hopkins review throws doubt on wound care treatment
23 hours ago
A systematic review of 66 research papers focused on the treatment of skin ulcers suggests that most are so technically flawed that their results are unreliable. And even of those that pass muster, there is only weak evidence ...
Antibiotics before heart surgery protect against infection
Dec 23, 2013
A new study found preoperative antibiotic therapy administered within two hours of cardiac surgery decreased the risk of developing surgical site infections (SSIs) significantly. The study was published in the January issue ...
User comments
© Medical Xpress 2011-2013, Science X network
0 comments:
Post a Comment